SCHEMBL12797478

SCHEMBL12797478

Cc1ccc2cc3c(cc2c1)sc1c2ccc(C)cc2sc31

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.46
CYP1A2 P05177 5/20 0.46
TDP1 Q9NUW8 1/20 0.41
BCL2L1 Q07817 1/20 0.38
MCL1 Q07820 1/20 0.38
LMNA P02545 3/20 0.38
GAA P10253 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 4/20 0.36
RAB9A P51151 4/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12797655 0.98 CYP2A6 (0.45) CYP2A6CYP1A2TDP1BCL2L1MCL1
SCHEMBL12797656 0.95 CYP2A6 (0.42) CYP2A6CYP1A2TDP1BCL2L1MCL1
SCHEMBL10031388 0.94 CYP2A6 (0.52) CYP2A6CYP1A2TDP1BCL2L1MCL1
SCHEMBL17037120 0.94 CYP2A6 (0.52) CYP2A6CYP1A2TDP1BCL2L1MCL1
SCHEMBL10031363 0.94 CYP2A6 (0.52) CYP2A6CYP1A2TDP1BCL2L1MCL1
SCHEMBL16978710 0.94 BCL2L1 (0.41) CYP2A6CYP1A2BCL2L1MCL1LMNA
SCHEMBL12796848 0.93 CYP2A6 (0.50) CYP2A6CYP1A2TDP1BCL2L1MCL1
SCHEMBL12797658 0.92 CYP2A6 (0.42) CYP2A6CYP1A2TDP1BCL2L1MCL1
SCHEMBL18267821 0.91 CYP2A6 (0.48) CYP2A6CYP1A2TDP1BCL2L1MCL1
SCHEMBL18405844 0.91 CYP2A6 (0.48) CYP2A6CYP1A2TDP1BCL2L1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9260451-B2 Method for producing aromatic compound NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2016-02-16 US disclosed
EP-2483367-B1 ELECTROLUMINESCENT THIOPHENE DERIVATIVES LOMOX LTD (GB) 2015-09-16 EP disclosed
US-20150239901-A1 Method For Producing Aromatic Compound NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2015-08-27 US disclosed
US-9006435-B2 Electroluminescent thiophene derivatives LOMOX LIMITED (GB) 2015-04-14 US disclosed
US-9006435-B2 Electroluminescent thiophene derivatives LOMOX LIMITED (GB) 2015-04-14 US disclosed
US-20120271052-A1 ELECTROLUMINESCENT THIOPHENE DERIVATIVES LOMOX LIMITED (GB) 2012-10-25 US disclosed
US-20120271052-A1 ELECTROLUMINESCENT THIOPHENE DERIVATIVES LOMOX LIMITED (GB) 2012-10-25 US disclosed
WO-2011039505-A1 ELECTROLUMINESCENT THIOPHENE DERIVATIVES LOMOX LIMITED (GB) 2011-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120271052-A1 ELECTROLUMINESCENT THIOPHENE DERIVATIVES AR, NR2E3, NES CYP2A6 2867/4885CYP1A2 3437/4885TDP1 2043/4885
US-20150239901-A1 Method For Producing Aromatic Compound TYR, XDH, CYP1A1 CYP2A6 125/4885CYP1A2 8/4885TDP1 3801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.